• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2006 Fiscal Year Final Research Report Summary

Basic and Clinical Studies on Natural Antioxidant Astaxanthin on the Inhibition of Diabetic Complication

Research Project

Project/Area Number 16300240
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Eating habits, studies on eating habits
Research InstitutionJapan Women's University

Principal Investigator

NGUYEN Van Chuyen  Japan Women's Univ., Fac. of Home Economics, Prof., 家政学部, 教授 (80175322)

Co-Investigator(Kenkyū-buntansha) KAWAKAMI Masanobu  Jichi Medical School, Professor, 医学部, 教授 (40161286)
KUROKI Masatoshi  Jichi Medical School, Associate Professor, 医学部, 助教授 (90215096)
Project Period (FY) 2004 – 2006
KeywordsDiabetes / Astaxanthin / Tocopherol / Tocotrienol / Ascorbic acid / Flavengenol / Cataract / Antioxidant
Research Abstract

In this study, Astaxanthin, a kind of Carotenoid, was used in combination with other antioxidants such as Tocopherol, Tocotrienol, Ascorbic acid or Flavengenol (a mixture of polyphenols from pine) in diabetic rats, to confirm the effectiveness of these combinations against oxidative stress and diabetic complications.
The experiments were carried out on STZ diabetic rats, then, the following results were confirmed : In the diabetic rats fed with Astaxanthin in combination with Tocopherol or Tocotrienol the strong inhibition of oxidative stress was observed. The 8-OHdG biomarker in urine of diabetic rats was also lower than that of the control. However, in the diabetic rats fed with Astaxanthin in combination with high dose of Ascorbic acid, the lipid peroxide was higher than that of the control. From this result, it can be concluded that high dose of Ascorbic acid accelerated the oxidation in vivo. Besides, by the combination with Astaxanthin, the comsumption of Tocopherol was reduced, t … More hen the concentration of Tocopherol in serum and internal organs were increased.
Moreover, water soluble Flavengenol was used in the combination with Astaxanthin for the inhibition of diabetic complications. Then, the results showed that with the combination with Flavengenol, the lipid peroxide in liver, kidney and serum were lower than that of the control. The degree of cataract was also lower than that of the control. The 8-OHdG biomarker in urine was also lower than that of the control. From these results, Astaxanthin by the combination with Flavangenol, the inhibition of lipid peroxide in diabetic rats was significant.
From these above results, Astaxanthin in the combination with Tocopherol, Tocotrienol or Flavengenol was effective for the inhibition of diabetic complications. Diabetes is increasing in developed and developing countries. For the inhibition of diabetic complications, it is hoped that the results in this study will be reference for the prevention method of diabetic complications. The clinical trials in human will be carried out in the coming year, in the hospital.. Less

  • Research Products

    (4 results)

All 2007 2004

All Journal Article (2 results) Book (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Product for the Prevention of Diabetic Complications2007

    • Author(s)
      Nguyen Van Chuyen et al.
    • Journal Title

      Patent Application : Applicants, Toyo Shinyaku Co., Ltd & Fuji Chemicals Co., Ltd Application No: PJ070530

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] The Effectiveness of Food Colorants in Diabetes2004

    • Author(s)
      Nguyen Van Chuyen
    • Journal Title

      Name of the book : The Sciences of Colorants in Foods (Sciences Forum Publisher, Japan)

      Pages: 9

    • Description
      「研究成果報告書概要(欧文)」より
  • [Book] 色から見た食品のサイエンス(分担)機能性色素と糖尿病の予防2004

    • Author(s)
      グュエン ヴァン チュエン
    • Total Pages
      9
    • Publisher
      サイエンスフォーラム
    • Description
      「研究成果報告書概要(和文)」より
  • [Patent(Industrial Property Rights)] 糖尿病併発疾病予防剤2007

    • Inventor(s)
      グュエンヴァンチュエン等
    • Industrial Property Rights Holder
      (株)東洋新薬, 富士化学工業(株)
    • Industrial Property Number
      特許願、PJ070530
    • Filing Date
      2007-05-30
    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2008-05-27   Modified: 2021-04-07  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi